Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Background In an attempt to prevent overly aggressive treatment of low-risk thyroid cancers,
the American Thyroid Association changed guideline recommendations in late 2015 to state …

Introduction: In the past, total thyroidectomy was usually recommended as the initial
therapeutic approach in all but the lowest risk differentiated thyroid cancers. Today, many …

Background: Surgical extent in the management of well-differentiated thyroid cancer (DTC)
remains a recurrent subject of debate. This is especially relevant in low-risk DTC of 1–4 cm …

The surgical management of papillary thyroid carcinoma remains contentious and the
optimal surgical strategy has not been yet established. The extent of thyroid resection has …

Abstract Background The 2015 American Thyroid Association guidelines recommended
either total thyroidectomy or lobectomy for surgical treatment of low-risk differentiated thyroid …